Press release: PROIBS® ranked as best-selling IBS product in Sweden
Calmino enters 2026 as market leader – PROIBS® was Sweden’s No. 1 IBS product in 2025 Gothenburg, Sweden – Calmino group AB begins 2026 with a significant strategic milestone. According to sales data from IQVIA, PROIBS® was the best-selling IBS product in Swedish pharmacies during the full year 2025, positioning PROIBS® as the No. 1 […]
Calmino & Immuron Limited partner to bring ProIBS® to AUSTRALIA
CALMINO GROUP AB AND IMMURON LIMITED JOIN THE TREAMENT OF SYMPTOMS OF IRRITABLE BOWEL SYNDROME (IBS) Gothenburg, Sweden, 11th of March, 2024 Calmino group AB (Göteborg, Sweden) and Immuron Limited (Melbourne, Australia, ASX: IMC; NASDAQ: IMRN) have entered an exclusive distribution agreement for the territory of Australia and New Zealand to launch ProIBS® for the […]
Launch of PROIBS® – now in Switzerland
Calmino group AB is proud to announce that PROIBS® has just been launched in a new country within Europe. This time it’s the company Alfasigma Schweiz AG who launched PROIBS® in Switzerland. By launching PROIBS® in the heart of Europe, we look forward to expanding our markets further with supported studies within IBS and Gut Health in Gothenburg […]
Launching PROIBS® television commercial
Launching PROIBS® in a new country in the midst of a pandemic has been eventful for Calmino to say the least. But there is cause for optimism, and technology will be key. It is exciting for Calmino group to announce that PROIBS® television commercials has been aired successfully in several big television channels in Greece for several weeks […]
Launch of PROIBS® in Greece!
We are proud to announce that PROIBS® is now available in Greece following our partnership with Pharmaserve Lilly. PROIBS® is a certified medical device product for the treatment of symptoms related to IBS such as abdominal pain, bloating and changes in bowel movement (diarrhoea and/or constipation). How does PROIBS® work? Watch the video below to see how PROIBS® works. […]